|
Originally published In Press as doi:10.1074/jbc.M006574200 on October 18, 2000
J. Biol. Chem., Vol. 276, Issue 5, 3333-3340, February 2, 2001
Ligand-independent Dimerization and Activation of the Oncogenic
Xmrk Receptor by Two Mutations in the Extracellular Domain*
Ana
Gómez ,
Claudia
Wellbrock,
Heidrun
Gutbrod,
Nicola
Dimitrijevic§, and
Manfred
Schartl¶
From Physiological Chemistry I, Biocenter (Theodor Boveri
Institute), University of Würzburg, Am Hubland,
97074 Würzburg, Germany
Overexpression of the oncogenic receptor tyrosine
kinase ONC-Xmrk is the first step in the development of
hereditary malignant melanoma in the fish Xiphophorus.
However, overexpression of its proto-oncogene counterpart
(INV-Xmrk) is not sufficient for the oncogenic function of
the receptor. Compared with INV-Xmrk, the ONC-Xmrk receptor displays 14 amino acid changes, suggesting the presence of activating mutations. To
identify such activating mutations, a series of chimeric and mutant
receptors were studied. None of the mutations present in the
intracellular domain was found to be involved in receptor activation.
In the extracellular domain, we found two mutations responsible for
activation of the receptor. One is the substitution of a conserved
cysteine (C578S) involved in intramolecular disulfide bonding. The
other is a glycine to arginine exchange (G359R) in subdomain III.
Either mutation leads to constitutive dimer formation and thereby to
activation of the ONC-Xmrk receptor. Besides, the presence of these
mutations slows down the processing of the Xmrk receptor in the
endoplasmic reticulum, which is apparent as an incomplete glycosylation.
*
This work was supported by grants from Deutsche
Forschungsgemeinschaft (Sonderforschungsbereich 487: Regulatorische
Membranproteine, Graduiertenkolleg: Zellwachstum) and Fonds der
Chemischen Industrie.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Inst. de Acuicultura Torre la Sal, 12595 Castellón, Spain.
§
Present address: Augsburg Hospital, Inst. for Pathology, D-86156
Augsburg, Germany.
¶
To whom correspondence should be addressed. Tel.:
49-931-8884148; Fax: 49-931-8884150; E-mail: phch1@biozentrum.uni-
wuerzburg.de.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Meierjohann, E. Wende, A. Kraiss, C. Wellbrock, and M. Schartl
The oncogenic epidermal growth factor receptor variant xiphophorus melanoma receptor kinase induces motility in melanocytes by modulation of focal adhesions.
Cancer Res.,
March 15, 2006;
66(6):
3145 - 3152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gomez, J.-N. Volff, U. Hornung, M. Schartl, and C. Wellbrock
Identification of a Second egfr Gene in Xiphophorus Uncovers an Expansion of the Epidermal Growth Factor Receptor Family in Fish
Mol. Biol. Evol.,
February 1, 2004;
21(2):
266 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|